BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25473092)

  • 1. Evaluation of Subcutaneous Phenobarbital Administration in Hospice Patients.
    Hosgood JR; Kimbrel JM; McCrate Protus B; Grauer PA
    Am J Hosp Palliat Care; 2016 Apr; 33(3):209-13. PubMed ID: 25473092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Home Palliative Sedation Using Phenobarbital Suppositories: Time to Death, Patient Characteristics, and Administration Protocol.
    Setla J; Pasniciuc SV
    Am J Hosp Palliat Care; 2019 Oct; 36(10):871-876. PubMed ID: 30947512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palliative Sedation at the End of Life: Patterns of Use in an Israeli Hospice.
    Azoulay D; Shahal-Gassner R; Yehezkel M; Eliyahu E; Weigert N; Ein-Mor E; Jacobs JM
    Am J Hosp Palliat Care; 2016 May; 33(4):369-73. PubMed ID: 25701661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the use of sedatives in a hospital support team and in a hospice.
    Stone P; Phillips C; Spruyt O; Waight C
    Palliat Med; 1997 Mar; 11(2):140-4. PubMed ID: 9156110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of label and off-label drugs by the subcutaneous route in palliative care: an observational cohort study.
    Jensen JJ; Sjøgren P
    BMJ Support Palliat Care; 2022 Dec; 12(e6):e723-e729. PubMed ID: 32887729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safe Use of Subcutaneous Diphenhydramine in the Inpatient Hospice Unit.
    Chen A; Loquias EJ; Roshan R; Levene R; Zelhof R; Hickey T; Cooney GA; Gonzalez F
    Am J Hosp Palliat Care; 2017 Dec; 34(10):954-957. PubMed ID: 27625354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophilic myocarditis associated with toxicodermia caused by phenobarbital.
    Arima M; Kanoh T; Yamasaki A; Matsuda S; Kasuya H; Sunayama S; Kawai S; Okada R
    Jpn Circ J; 1998 Feb; 62(2):132-5. PubMed ID: 9559433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenobarbital for mild sedation: market withdrawal.
    Prescrire Int; 2001 Aug; 10(54):120. PubMed ID: 11718185
    [No Abstract]   [Full Text] [Related]  

  • 9. Induration at Injection or Infusion Site May Reduce Bioavailability of Parenteral Phenobarbital Administration.
    Nakayama H; Echizen H; Ogawa R; Akabane A; Kato T; Orii T
    Ther Drug Monit; 2017 Jun; 39(3):297-302. PubMed ID: 28328763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenobarbital and perinatal asphyxia.
    Donn SM
    J Pediatr; 1998 Nov; 133(5):714. PubMed ID: 9821439
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical impact of a home-based palliative care program: a hospice-private payer partnership.
    Kerr CW; Tangeman JC; Rudra CB; Grant PC; Luczkiewicz DL; Mylotte KM; Riemer WD; Marien MJ; Serehali AM
    J Pain Symptom Manage; 2014 Nov; 48(5):883-92.e1. PubMed ID: 24747224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Transdermal Administration of Phenobarbital in Healthy Cats.
    Krull DP; Thomovsky SA; Chen AV; Mealey KL; Papich MG
    J Am Anim Hosp Assoc; 2019; 55(1):1-7. PubMed ID: 30427717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of palliative sedation therapy: a multicenter, prospective, observational study conducted on specialized palliative care units in Japan.
    Morita T; Chinone Y; Ikenaga M; Miyoshi M; Nakaho T; Nishitateno K; Sakonji M; Shima Y; Suenaga K; Takigawa C; Kohara H; Tani K; Kawamura Y; Matsubara T; Watanabe A; Yagi Y; Sasaki T; Higuchi A; Kimura H; Abo H; Ozawa T; Kizawa Y; Uchitomi Y;
    J Pain Symptom Manage; 2005 Oct; 30(4):320-8. PubMed ID: 16256896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral phenobarbital loading: a safe method of barbiturate and nonbarbiturate hypnosedative withdrawal.
    Janecek E; Kapur BM; Devenyi P
    CMAJ; 1987 Sep; 137(5):410-2. PubMed ID: 3621099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospice care: what services do patients and their families receive?
    Carlson MD; Morrison RS; Holford TR; Bradley EH
    Health Serv Res; 2007 Aug; 42(4):1672-90. PubMed ID: 17610443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous Drugs and Off-label Use in Hospice and Palliative Care: A Scoping Review.
    Wernli U; Dürr F; Jean-Petit-Matile S; Kobleder A; Meyer-Massetti C
    J Pain Symptom Manage; 2022 Nov; 64(5):e250-e259. PubMed ID: 35870656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phenemal and alcoholic ketoacidosis].
    Benjaminsen SE
    Ugeskr Laeger; 2008 Sep; 170(37):2895; author reply 2896. PubMed ID: 18807649
    [No Abstract]   [Full Text] [Related]  

  • 18. [The subcutaneous administration of a NSAID in palliative care].
    Menegaldo L
    Clin Ter; 1992 Oct; 141(10):273-8. PubMed ID: 1281764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Is the Earth round or flat as a pancake?].
    Becker U
    Ugeskr Laeger; 2008 Aug; 170(33):2471; author reply 2472. PubMed ID: 18763379
    [No Abstract]   [Full Text] [Related]  

  • 20. Ethical validity of palliative sedation therapy: a multicenter, prospective, observational study conducted on specialized palliative care units in Japan.
    Morita T; Chinone Y; Ikenaga M; Miyoshi M; Nakaho T; Nishitateno K; Sakonji M; Shima Y; Suenaga K; Takigawa C; Kohara H; Tani K; Kawamura Y; Matsubara T; Watanabe A; Yagi Y; Sasaki T; Higuchi A; Kimura H; Abo H; Ozawa T; Kizawa Y; Uchitomi Y;
    J Pain Symptom Manage; 2005 Oct; 30(4):308-19. PubMed ID: 16256895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.